Medical device and Drugs trial converge, so does Pharma and Medtech CROs

The statement above is on grounds of recent uptick that clinical research industry is witnessing on supply front. Couple of days back we had published CSSI Lifescience’s launch of fully integrated medical device CRO, and now CiToxLAB acquiring AccelLAB.

The trend of acquisitions is justifiable, as Healthcare industry embraces convergence of medical devices and drugs. Combination products are buzz words of healthcare industry and no CRO; big or small are leaving any stone un-turned to address booming client need.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s